Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-23-007322
Filing Date
2023-04-28
Accepted
2023-04-28 17:07:48
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ampe-20221231x10ka.htm   iXBRL 10-K/A 538618
2 EX-31.3 ampe-20221231xex31d3.htm EX-31.3 4752
3 EX-31.4 ampe-20221231xex31d4.htm EX-31.4 4291
4 GRAPHIC ampe-20221231x10ka004.jpg GRAPHIC 2317
  Complete submission text file 0001558370-23-007322.txt   784301

Data Files

Seq Description Document Type Size
5 EX-101.SCH ampe-20221231.xsd EX-101.SCH 3141
6 EX-101.LAB ampe-20221231_lab.xml EX-101.LAB 24815
7 EX-101.PRE ampe-20221231_pre.xml EX-101.PRE 15545
9 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20221231x10ka_htm.xml XML 8332
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35182 | Film No.: 23868132
SIC: 2834 Pharmaceutical Preparations